Table 2.
Pharmacological therapy
| NSVT (n = 179) | No NSVT (n = 90) | P value | |
|---|---|---|---|
| Ia | 1 (0.6) | 1 (1.1) | .619 |
| Ib | 2 (1.1) | 1 (1.1) | .996 |
| Ic | 0 (0.0) | 1 (1.1) | .158 |
| β‐blockers | 141 (78.8) | 63 (70.0) | .113 |
| III | 67 (37.4) | 26 (28.9) | .165 |
| Ca2+ antagonists | 12 (6.7) | 6 (6.7) | .991 |
| Digitalis | 24 (13.4) | 10 (11.1) | .593 |
| Diuretics | 147 (82.1) | 66 (73.3) | .094 |
| ACEI/ARB | 125 (69.8) | 67 (74.4) | .430 |
| Aldosterone antagonists | 93 (52.0) | 34 (37.8) | .028 |
| Nitrates | 24 (13.4) | 10 (11.1) | .593 |
| Statins | 53 (29.6) | 37 (41.1) | .059 |
| Oral anticoagulant agents | 99 (55.3) | 36 (40.0) | .018 |
| Antiplatelet agents | 58 (32.4) | 43 (47.8) | .014 |
ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II‐receptor blocker.
Data are given as number (%).